How many patents does
Universitaet Regensburg have?
patents
399
families
86
granted
85
applications
314
US
92
EP
88
WO
69
CN
26
JP
15
KR
9
GB
1
RoW
99
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Universitaet Regensburg
Top ten assignees appearing on patents
2009 - 2018
| merck patent | 41 |
| sequenom | 13 |
| hyperthermics holding | 11 |
| biocer entwicklungs | 8 |
| pfm medical titanium | 5 |
| cynora | 5 |
| novartis | 5 |
| intana bioscience | 4 |
| c3 prozess- und analysentechnik | 3 |
| protagen | 3 |
2018
| sequenom | 2 |
| pfm medical titanium | 1 |
Universitaet Regensburg
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| peptide antagonists of the vasopressin-2 receptor | 21 | 2012 |
| energy production with hyperthermophilic organisms | 15 | 2006 |
| kits and methods for detecting methylated dna | 14 | 2004 |
| il-3 inhibitors in use for treatment of rheumatoid arthritis in an early stage | 12 | 2008 |
| means and methods for detecting methylated dna | 11 | 2004 |
| a prognostic and therapeutic signature for malignant melanoma | 11 | 2011 |
| solution of lipophilic substances, especially medicinal solutions | 10 | 2008 |
| 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the prodcution and use ther… 🛈 | 10 | 2015 |
| phosphorus-containing metal complexes | 10 | 2010 |
| cross-linked polymer matrix, in particular for administering active ingredients | 10 | 2008 |